Freire Maria C
SEC CIK 1547999 · EDGAR
BoughtSold
Most active insiders at BIIB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Singhal Priya | Head of Development | — | $665.7K |
| 2 | Minor Lloyd | Dir | — | $239.7K |
| 3 | Murphy Nicole | Head of Pharm Ops, Tech | $585.12 | — |
| 4 | Godbout Sean | CAO | — | — |
| 5 | Pangalos Menelas N | Dir | — | — |
| 6 | Grogan Jane | Head of Research | — | — |
| 7 | LANGER SUSAN | Dir | — | — |
| 8 | Keeney Adam | Head of Corp. Development | — | — |
| 9 | Izzar Rachid | Head of Gbl Product Strat | — | — |
| 10 | Patolawala Monish D | Dir | — | — |
| 14 | Freire Maria C | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-11 17:09 | 2026-06-09 | BIIB | Biogen | Freire Maria C | Dir | A - Grant | $0.00 | +2,005 | 8,820 | +29% | $0 | |
| 2026-05-29 17:43 | 2026-05-27 | EXEL | EXELIXIS, INC. | Freire Maria C | Dir | A - Grant | $0.00 | +8,367 | 109.2K | +8% | $0 | |
| D | 2026-05-08 19:03 | 2026-05-07 | EXEL | EXELIXIS, INC. | Freire Maria C | Dir | M - OptEx | $19.77 | +20.6K | 121.5K | +20% | +$407.9K |
| D | 2026-05-08 19:03 | 2026-05-07 | EXEL | EXELIXIS, INC. | Freire Maria C | Dir | S - Sale+OE | $46.00 | -20.6K | 100.8K | -17% | -$949.2K |
| 2026-01-20 | 2026-01-15 | ARE | Alexandria Real Estate Equities | Freire Maria C | Dir | A - Grant | $0.00 | +3,493 | 10.9K | +47% | $0 | |
| 2025-06-18 | 2025-06-17 | BIIB | Biogen | Freire Maria C | Dir | A - Grant | $0.00 | +2,370 | 6,815 | +53% | $0 | |
| 2025-05-30 | 2025-05-29 | EXEL | EXELIXIS, INC. | Freire Maria C | Dir | A - Grant | $0.00 | +9,812 | 100.8K | +11% | $0 | |
| DM | 2025-02-19 | 2025-02-14 | EXEL | EXELIXIS, INC. | Freire Maria C | Dir | M - OptEx | $21.52 | +44.1K | 106.9K | +70% | +$949.5K |
| D | 2025-02-19 | 2025-02-14 | EXEL | EXELIXIS, INC. | Freire Maria C | Dir | S - Sale+OE | $34.94 | -44.1K | 91.0K | -33% | -$1.54M |
| 2025-01-17 | 2025-01-15 | ARE | Alexandria Real Estate Equities | Freire Maria C | Dir | A - Grant | $0.00 | +2,032 | 7,453 | +37% | $0 | |
| 2024-08-16 | 2024-08-14 | EXEL | EXELIXIS, INC. | Freire Maria C | Dir | S - Sale | $26.56 | -8,250 | 91.0K | -8% | -$219.1K | |
| 2024-06-25 | 2024-06-21 | BIIB | Biogen | Freire Maria C | Dir | A - Grant | $0.00 | +1,340 | 4,445 | +43% | $0 | |
| 2024-06-04 | 2024-05-31 | EXEL | EXELIXIS, INC. | Freire Maria C | Dir | A - Grant | $0.00 | +18.8K | 99.3K | +23% | $0 | |
| 2024-01-17 | 2024-01-12 | ARE | Alexandria Real Estate Equities | Freire Maria C | Dir | A - Grant | $0.00 | +1,585 | 5,421 | +41% | $0 | |
| 2023-06-28 | 2023-06-26 | BIIB | Biogen | Freire Maria C | Dir | A - Grant | $0.00 | +960 | 3,105 | +45% | $0 | |
| 2023-06-02 | 2023-06-01 | EXEL | EXELIXIS, INC. | Freire Maria C | Dir | A - Grant | $0.00 | +20.7K | 80.4K | +35% | $0 | |
| 2023-01-18 | 2023-01-13 | ARE | Alexandria Real Estate Equities | Freire Maria C | Dir | A - Grant | $0.00 | +1,125 | 3,836 | +41% | $0 | |
| M | 2022-08-01 | 2022-07-28+ | ARE | Alexandria Real Estate Equities | Freire Maria C | Dir | S - Sale | $163.21 | -2,600 | 3,000 | -46% | -$424.4K |
| 2022-06-17 | 2022-06-15 | BIIB | Biogen | Freire Maria C | Dir | A - Grant | $0.00 | +1,370 | 2,145 | +177% | $0 | |
| 2022-05-27 | 2022-05-26 | EXEL | EXELIXIS, INC. | Freire Maria C | Dir | A - Grant | $0.00 | +19.6K | 59.7K | +49% | $0 | |
| 2022-01-19 | 2022-01-14 | ARE | Alexandria Real Estate Equities | Freire Maria C | Dir | A - Grant | $0.00 | +738 | 5,311 | +16% | $0 | |
| 2021-07-02 | 2021-07-01 | BIIB | Biogen | Freire Maria C | Dir | A - Grant | $0.00 | +775 | 775 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations